SEC Company Response from ACCREDO HEALTH INC (CIK 0001068887) — Apr 22, 2005

ACCREDO HEALTH INC (CIK 0001068887)
Date: April 22, 2005 · CIK: 0001068887 · Accession: 0000950144-05-004238

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-25769

Date

April 22, 2005

Author

/s/ Joel R. Kimbrough

Form

CORRESP

Company

ACCREDO HEALTH INC (CIK 0001068887)

Letter

VIA EDGAR AND UPS OVERNIGHT United States Securities and Exchange Commission Re: Accredo Health, Incorporated (the “Company”) Form 10-K for the fiscal year ended June 30, 2004 File No. 000-25769

Dear Mr. Rosenberg:

With regard to the above filing, Accredo Health, Incorporated acknowledges as follows:

• The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

• Staff comments or changes to disclosure in response to staff comments in the filing reviewed by the staff do not foreclose the Commission from taking any action with respect to the filing; and

• The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,
/s/ Joel R. Kimbrough

Show Raw Text

CORRESP
1
filename1.htm

ACREDO HEALTH, INCORPORATED

April 22, 2005

VIA EDGAR AND UPS OVERNIGHT

Jim B. Rosenberg

Senior Assistant Chief Accountant

United States Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, D.C. 20549

    Re:

    Accredo Health, Incorporated (the “Company”)

    Form 10-K for the fiscal year ended June 30, 2004

    File No. 000-25769

Dear Mr. Rosenberg:

     With regard to the above filing, Accredo Health, Incorporated acknowledges as follows:

    •
    The Company is responsible for the adequacy and accuracy of the
disclosure in the filing;

    •
    Staff comments or changes to disclosure in response to staff
comments in the filing reviewed by the staff do not foreclose the
Commission from
taking any action with respect to the filing; and

    •
    The Company may not assert staff comments as a defense in any
proceeding initiated by the Commission or any person under the federal
securities laws of the United States.

Sincerely,

/s/ Joel R. Kimbrough

Joel R. Kimbrough

Senior Vice President, Chief Financial

Officer, and Treasurer

SecProbe.io